Nigeria prioritising four COVID-19 vaccines, not including Sinopharm

FILE PHOTO: Dr Ngong Cyprian receives his first dose of the Oxford/AstraZeneca coronavirus disease (COVID-19) vaccine from Dr Faisal Shuaib, Executive Director and Chief Executive Officer of the National Primary Health Care Development Agency, at the National hospital in Abuja, Nigeria, March 5, 2021. REUTERS/Afolabi Sotunde/File Photo

ABUJA, Aug 31 – Nigeria is prioritising the AstraZeneca, Pfizer, Moderna and Johnson & Johnson vaccines against COVID-19, the head of the country’s primary healthcare agency said on Tuesday when asked whether the Sinopharm vaccine would be used in the country.

Faisal Shuaib said the Sinopharm shot had been approved by the Nigerian medicines regulator “for emergency use”, but rolling it out was not a priority.